PHR3041
Comprehensive care: Blood, brain and cancers
基本信息
| 学分 | 12 credit points |
|---|---|
| 开课学期 | First semester |
| 校区 | Malaysia |
| 考核构成 | Final examination — 50% Workshop case-based assessment 2 — 5% Workshop case-based assessment 4 — 10% Mid semester test — 15% Workshop case-based assessment 1 — 5% Workshop case-based assessment 3 — 5% MyPharm engagement — 5% Individual Readiness Assurance tests — 5% |
开课安排1 条
| 教学期 | 授课方式 | 状态 |
|---|---|---|
| First semester | Teaching activities are on-campus (ON-CAMPUS) | 开课 |
以上为该校区在官方资料中登记的全部开课安排，不是汇总。同一门课可能在多个 教学期开课，也可能不同教学期的授课方式不同。
课程简介
This unit provides the knowledge and skills required for the therapeutic management of patients with selected blood and brain conditions as well as cancers. Specifically, the unit will cover conditions involving the brain such as depression and schizophrenia, conditions affecting blood such as anaemias, and cancers such as leukaemia and lung cancer. You will relate the pathophysiology and epidemiology of these conditions to the rational design and clinical use of medicines. The pharmacology, disposition, and clinical and therapeutic aspects of medicines associated with each condition will be presented in an integrated fashion. This unit will involve the development of pharmacy relevant skills such as critical thinking and oral and written communication skills. Quality use of medicines principles will be emphasised, enabling you to acquire the skills necessary to optimise patient outcomes in different cultural settings.
以上为 Monash Handbook 的官方原文，版权属 Monash University，此处按本站要求转载并标注出处： 官方页面 ↗
学习成果7 条
官方原文（Learning outcomes），版权属 Monash University。
- ULO1 Describe the pathophysiology, epidemiology and clinical aspects of disease state management of selected blood and brain conditions, and cancers
- ULO2 Interpret the signs and symptoms, and laboratory parameters associated with a range of blood and brain conditions, and cancers
- ULO3 Explain the molecular basis of drug action and/or the mechanism of action of drugs used in treatment of selected blood and brain conditions, and cancers, and predict therapeutic outcomes and potential adverse effects based on pharmacodynamic and pharmacokinetic principles
- ULO4 In the context of a pharmacist and a standardised approach to patient centred care (e.g. Monash Model of CARE) in patients' with a blood or brain condition and/or cancer: (i) Gather and integrate information concerning the pharmacology pharmacokinetic characteristics of medicines, clinical aspects of disease state management, and patient specific factors to identify and appraise potential management options (ii) Create a medication management plan which incorporates established clinical guidelines and a comprehensive clinical review of medicine-related problems (iii) Prioritise and rationalise drug and non-drug therapy options for condition management (iv) Evaluate clinical scenarios to determine when medical referral is necessary, particularly for symptoms indicating urgent care (v) Create, apply and communicate education strategies that provide support and optimise patient-centred relationships and outcomes
- ULO5 Reflect on the development and implementation of the Monash model of CARE plan and other key skills relevant to pharmacy practice.
- ULO6 Demonstrate effective collaboration within a multidisciplinary healthcare team to develop and articulate evidence-based clinical and communication strategies for the management of selected blood and brain conditions, and cancers.
- ULO7 Demonstrate an integrated understanding of key concepts from previous professional practice and comprehensive care topics, promoting a holistic approach to patient care.
教学方式与预期工作量
教学方式
Active learning
预期工作量
• One hundred and forty-four hours of independent study
• Forty-eight hours of pre-learning activities (up to 4 hours per week)
• Fifty-nine hours of active learning applied sessions (4 hours a week)
• Thirty-nine hours of small group classes including assessment (4 hours per week)
• Three 1-hour skills coaching sessions
官方原文，版权属 Monash University。
先修 / 同修要求
以下先修关系按官方来源的结构化先修字段解析，原始记号：PHR1222 AND PHR1122 AND PHR1011 AND PHR1021 AND PHR1012 AND PHR2041 AND PHR2142 AND PHR2011 AND PHR2141 AND PHR1022 AND PHR2012 AND PHR1031 AND PHR2021 AND PHR2042
修完这门课可以衔接
先修链路
按官方先修字段的原始分组展开，AND / OR 的区别保留着—— 「A 或 B」和「A 与 B」在选课时是两回事。每门课点进去可以继续往下看。
属于这些学位1 个
这门课出现在下列学位的官方结构里。反过来说：如果你读的是这些学位之一，它大概率是要修的 （必修还是选修取决于它在 Part 里的位置，点进去看结构）。
数据来源
- 数据来源
- 官方网页
handbook.monash.edu ↗ - 抓取时间
- 2026-09-13
- 可信度
- 程序抓取，未人工核实
查看官方完整描述 ↗ — 事实性字段（代码、学分、教学期、授课方式、考核权重、先修/同修/互斥关系）与 课程简介、学习成果、教学方式、预期工作量均取自官方 Handbook； 正文版权属 Monash University，此处转载并逐处标注出处。
发现信息有误？告诉我们。请用自己的话描述问题，不要上传成绩单、截图或校内系统文件。